C-Path founder Raymond L. Woosley, MD, PhD announces retirement plans.
Critical Path Institute’s (C-Path) Board of Directors today announced that President, CEO, and Chairman of the Board, Raymond L. Woosley, MD, PhD, has informed them of his plan to retire as President effective January 31, 2012. The Board is now beginning the search and recruitment process for his successor. Dr. Woosley plans to remain actively involved in C-Path and will continue serving on the Board of Directors and leading C-Path’s Arizona Center for Education and Research on Therapeutics (AzCERT).
In 2005, Dr. Woosley launched C-Path to fill an essential role as a neutral, trusted third party in the drug development process, bringing together scientists from the U.S. Food and Drug Administration (FDA) and the regulated pharmaceutical industry to reach consensus on more reliable testing methods so that safe, new medications can reach the market quickly and efficiently. Under his leadership, C-Path has grown to include 53 highly qualified scientists, data experts, project managers, and executive staff. It has offices, laboratories, and a training facility in Tucson, AZ, offices in Rockville, MD, and offices and a laboratory at the Biodesign Institute at Arizona State University in Tempe, AZ.